Featured Opinions
Adherence Arena: The top 5 medication adherence myths
To improve patient adherence, we first need to puncture some myths
How pharma can utilize Google+
Branded pages are coming to Google+. What does it mean for pharma?
How technology can improve adherence, create loyalty, and decrease costs
The non-profit CFTechnology is devising digital solutions to help people with cystic fibrosis
ROTF: Meet Dave, model rep of the future
by Jeff Gaus
Why do remote reps use digital tools to interact with co-workers and traditional tools to interact with customers?
5 pitfalls to developing strong business acumen
by Steven Rosen
Sales leaders need to be clear on the obstacles to business acumen
Patients’ Week 2011: “The essence of Health 2.0 is collaboration”
by Sara Riggare
How being an informed patient helps Sara Riggare, who has Parkinson’s disease, achieve her goal of chronic health
Pharma innovation and rare disease research
Why rare disease research is good for pharma and good for patients
M’s the word: Who can you trust?
Why pharma should become more like your local barber - or a Disney hotel
by jeff
Will sales reps always be at the top of the budgetary food chain?
New pharma Facebook landscape: Comments allowed
by EileenOBrien
How is pharma responding to changes to Facebook's commenting policy?
Can a Patient Ever Know Too Much?
by EileenOBrien
Patients and caregivers can play a critical role in their diagnosis
M’s the word: Guns, fast cars and marketing
To succeed in marketing, remember the cultural context in which you are working
Pharma: are you a transparency wannabe?
How many times in the last year or so have you participated in planning sessions where the discussion centers on the strong desire for the brand or company to be perceived as trustworthy, to act with transparency and authenticity?
Turning pharma hallway calls into sales growth
The payoff for successful hallway calls can be enormous
Why pharma marketers need to rethink their attitude to change
While everything about pharma seems to be changing, one thing hasn't: Meeting the needs of customers
How business acumen can fuel pharma sales growth
by Steven Rosen
Business acumen is a critical sales skill for the new era of leaner and meaner sales forces
Adherence Arena: What is the real cost of non-adherence?
The higher the rate of non-adherence, the greater our sense of urgency should be
Mal’s Musings: Why Google Health is a step too far
The social media revolution may be great, but it's not always right when it comes to healthcare
Pharma DTC at the Crossroads? 2011 Prevention DTC Study Results
Here are six thought starters I see coming out of Prevention Magazine’s 14th Annual Pharmaceutical Direct-to-Consumer (DTC) Advertising Study.*
5 tips for successful patient outreach
by Anonymous (not verified)
As patients increasingly drive their own medical care, the value of direct, two-way conversation between biopharma and patients also increases.
Patients, orphan drugs and pricing controversies
by EileenOBrien
What the Makena backlash means for the rare disease community